API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
39
PharmaCompass offers a list of Quinapril API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Quinapril manufacturer or Quinapril supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Quinapril manufacturer or Quinapril supplier.
PharmaCompass also assists you with knowing the Quinapril API Price utilized in the formulation of products. Quinapril API Price is not always fixed or binding as the Quinapril Price is obtained through a variety of data sources. The Quinapril Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Quinapril hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Quinapril hydrochloride, including repackagers and relabelers. The FDA regulates Quinapril hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Quinapril hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Quinapril hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Quinapril hydrochloride supplier is an individual or a company that provides Quinapril hydrochloride active pharmaceutical ingredient (API) or Quinapril hydrochloride finished formulations upon request. The Quinapril hydrochloride suppliers may include Quinapril hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Quinapril hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Quinapril hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Quinapril hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Quinapril hydrochloride DMFs exist exist since differing nations have different regulations, such as Quinapril hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Quinapril hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Quinapril hydrochloride USDMF includes data on Quinapril hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Quinapril hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Quinapril hydrochloride suppliers with USDMF on PharmaCompass.
A Quinapril hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Quinapril hydrochloride Certificate of Suitability (COS). The purpose of a Quinapril hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Quinapril hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Quinapril hydrochloride to their clients by showing that a Quinapril hydrochloride CEP has been issued for it. The manufacturer submits a Quinapril hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Quinapril hydrochloride CEP holder for the record. Additionally, the data presented in the Quinapril hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Quinapril hydrochloride DMF.
A Quinapril hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Quinapril hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Quinapril hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Quinapril hydrochloride written confirmation (Quinapril hydrochloride WC) is an official document issued by a regulatory agency to a Quinapril hydrochloride manufacturer, verifying that the manufacturing facility of a Quinapril hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Quinapril hydrochloride APIs or Quinapril hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Quinapril hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Quinapril hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Quinapril hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Quinapril hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Quinapril hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Quinapril hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Quinapril hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Quinapril hydrochloride suppliers with NDC on PharmaCompass.
Quinapril hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Quinapril hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Quinapril hydrochloride GMP manufacturer or Quinapril hydrochloride GMP API supplier for your needs.
A Quinapril hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Quinapril hydrochloride's compliance with Quinapril hydrochloride specifications and serves as a tool for batch-level quality control.
Quinapril hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Quinapril hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Quinapril hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Quinapril hydrochloride EP), Quinapril hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Quinapril hydrochloride USP).